RVMD Revolution Medicines, Inc.
Healthcare$151.56-1.41%ClosedMarket Cap: $32.22B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
20.02
P/S
0.00
EV/EBITDA
-23.85
DCF Value
$0.88
FCF Yield
-3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-83.2%
ROA
-60.9%
ROIC
-70.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-445.2M | $-453.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-361.6M | $-364.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-1.18B | $-1.13B | $— | — |
| Q3 null | $0.00 | NaN% | $-315.3M | $-305.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-264.7M | $-247.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-240.8M | $-213.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-216.3M | $-194.6M | $— | — |
| FY null | $0.00 | NaN% | $-689.5M | $-600.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-175.7M | $-156.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-156.6M | $-133.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-140.9M | $-116.0M | $— | — |
| Q4 2023 | $742.0K | 100.0% | $-180.0M | $-161.5M | $-1.14 | — |